Skip to main content
BMC Research Notes logoLink to BMC Research Notes
. 2014 Mar 17;7:153. doi: 10.1186/1756-0500-7-153

Knowledge and attitudes towards use of long acting reversible contraceptives among women of reproductive age in Lubaga division, Kampala district, Uganda

Ronald Anguzu 1,, Raymond Tweheyo 1,3, Juliet N Sekandi 1,2, Vivian Zalwango 1, Christine Muhumuza 1, Suzan Tusiime 1, David Serwadda 1
PMCID: PMC3985592  PMID: 24636154

Abstract

Background

Uganda has one of the highest total fertility rates globally and in Sub-Saharan Africa. Her high fertility is mainly attributed to the high unmet need for family planning. Use of Long-acting reversible contraceptives (LARC) is low (13%) in Uganda yet they are the most cost-effective contraceptives. This study aimed to assess the reproductive aged women’s knowledge, attitudes, and factors associated with use of LARC.

Methods

A cross-sectional study was conducted involving 565 women (15–49 years) attending private and public health facilities in Lubaga division, Kampala district. Semi-structured questionnaires were used to measure knowledge, attitudes and factors associated with use of LARC; Intra-Uterine Devices, Implants and Injectables. The outcome variable was current use of LARC. A generalized linear regression model was run in STATA version12.0. Prevalence Risk Ratios for associations between current LARC use and independent factors were obtained and regarded significant at 95% CI with p < 0.05.

Results

Mean age (SD) and current use of LARC was 26.34 (5.35) and 31.7% respectively. Factors associated with current use of LARC were; previous use adj.PRR 2.89; (95% CI 2.29, 3.81), knowledge of implant administration site adj.PRR 1.83; (95% CI 1.17, 2.87), and perception that; male partner decisions positively influence their contraceptive choices adj.PRR 1.49; (95% CI 1.18, 1.88). Contrary, perception that LARC should be used by married women was negatively associated with use of LARC adj.PRR 0.63; (95% CI 0.44, 0.90).

Conclusion

Knowledge about site of administration, previous use of LARC and women’s attitude that male partners’ choice influence their contraceptive decisions were positively associated with current use of LARC. Contrary, the attitude that LARC was for married women was negatively associated with its use. This study suggests a need to strengthen client education about LARC to dispel possible myths and to consider integrating male partner’s decision making in contraceptive choices for women.

Keywords: Family planning, Long-acting reversible contraceptive (LARC), Injectable, Implant, IUD, Knowledge, Attitudes

Background

Uganda’s total fertility rate (TFR) at 6.2 is one of the highest in sub-Saharan Africa and globally [1]. Uganda more so, has a high maternal mortality ratio (MMR) at 435 maternal deaths per 100,000 live births and an infant mortality rate (IMR) of 54 per 1,000 live births per year [2]. High maternal morbidity and mortality could partly be attributed to unintended pregnancies, short birth intervals and higher risk of obstetric and newborn complications associated with low contraceptive use [3]. About 44% of pregnancies in Uganda are unintended [2] with occurrence of unsafe abortions estimated at 62 per 1,000 women aged 15–49 years [4]. These undesirable maternal and child health outcomes associated with high TFR could be substantially reduced by meeting the family planning (FP) needs of women in developing countries [5]. Provision of highly efficacious family planning (FP) services contributes to a reduction in maternal mortality by lowering the risk of maternal death per birth hence preventing high-risk and high-parity births [6]. It also offers individuals and couples’ ability to anticipate and attain the desired number of children by birth spacing and timing [7].

Use of long acting reversible methods is proposed as a strategy to reverse undesirable maternal health consequences in developing countries [8,9]. Scientific evidence has determined implant and copper-bearing Intra-Uterine Device (IUD) contraceptives to be highly effective and well tolerated [10,11]. Similarly, injectables and implants are proven to be safe, effective and reversible contraceptive options [12,13]. Despite evidence of LARC effectiveness and safety, actual uptake in resource-poor settings like Uganda is low, and is possibly affected by several factors such as knowledge and general awareness of contraceptive methods [14], access to different contraceptive methods, user characteristics, technology [15] and socio-economic status [16].

Currently in Uganda, the contraceptive prevalence rate (CPR) is 30% and LARC prevalence is as low as 13% among all women [2,17]. The prevalence of IUD use is lowest at 0.4%, implants as low as 1.9% and injectable contraceptives at 10.7% [2]. Kampala district, the study site, has a LARC prevalence of 22.7% with implant (1.6%), IUD (1.8%) and injectables (19.3%) [2]. This study set out to determine the reasons for low use of LARC in Lubaga division, Kampala, particularly assess knowledge and attitudes among women of reproductive age use of LARC attending reproductive health services.

Methods

A health facility-based, cross-sectional study was conducted for a period of nine weeks between March and April 2012 in Lubaga division. Lubaga is one of five administrative divisions in Kampala district, the capital of Uganda. The total population of the area is 411,900 with 53.6% females [18] and about 92% lives in peri-urban locations [19]. Lubaga division’s health structure is currently comprised of 124 registered health facilities and these are in three categories; 2 Public facilities, 120 private for profit and 2 Private Not-For-Profit (PNFP) which all provided reproductive health services including LARC services. The participants were both FP users and non-users who were females 15–49 years attending any reproductive health service (i.e. family planning, post-natal and outpatient clinics) in Lubaga division. A family planning user was defined as a woman who at the time of the interview was currently using any contraceptive method [2]. A non-FP user was defined as a woman who at the time of the interview had never used any contraceptive or had previously used a contraceptive but discontinued its use.

Data was entered, cleaned using Epi info 3.5.1 and statistical analysis done with STATA Version12.0. Data was collected using semi-structured interviewer administered questionnaires which contained information on independent variables. During administration of interviews, the respondents were not prompted with any contraceptive pictorials or FP product names. The outcome variable was binary i.e. current user or non-user of LARC methods. Prior to data collection, questionnaires were pre-tested at a non-participating health centre III in Nakawa division in Kampala that was purposively selected due to similarity of participants’ socio-cultural characteristics in order to determine their suitability for collecting study data and then editing of the data collection tools appropriately. Field editing of questionnaires was conducted by the supervisors on daily basis to check for completeness.

Sample size

The modified Kish, Leslie formula (1965) was used to estimate the sample size [20]. A total of 565 was computed using a 95% confidence interval, 3.5% precision, 20.5% prevalence for current use of LARC in Kampala district [21] and 9% of the sample size used to compensate for non-response [22]. Using probability proportionate-to-size of daily FP clinic attendance by category of health facility, 20 health facilities were selected. Among the total of 20 health facilities selected, 16 private clinics were randomly selected and 2 PNFP’s and 2 Public health facilities were purposively selected respectively. Probability proportionate-to-size sampling was used to select the number of participants to be recruited from each health facility. At each health facility, the first respondent from each clinic (FP, PNC and outpatient clinics) was selected randomly. The subsequent respondents were selected systematically from the daily clinic attendance list until the required respondents were selected.

Study measurements

The data was collected using a semi-structured questionnaire developed, piloted and translated into the predominant local language (Luganda) by the research team. Information on participants’ socio-demographic characteristics, LARC knowledge attitudes towards use of LARC was collected.

Knowledge of LARC

Participants’ knowledge was measured by the number of correct responses to 6 unprompted questions. The first three unprompted questions asked were on knowledge about duration of effective protection from pregnancy of IUD, implant and injectable contraceptives. The next three unprompted questions were on knowledge of the site of administration of IUD, implant and injectable contraceptives. A binary response to each question of yes or no was elicited.

Attitudes towards LARC

The items on attitude of participants towards use of LARC were scored using a 5-point likert scale with 5 responses. The responses were categorized as; ‘strongly agree’, ‘agree’, ‘not sure’, disagree’ and ‘strongly disagree’. These 5 responses where then collapsed into binary variables; agree and disagree. ‘Agree’ for those who responded ‘agree’ or ‘strongly agree’ and ‘disagree’ for those who responded ‘disagree’, ‘strongly disagree’ or ‘not sure’. This measurement is similar to a study in North Ethiopia which measured knowledge and attitudes towards long-acting and Permanent (LAPM) contraceptives [23].

Statistical analysis

Double data entry and cleaning was done in Epi info 3.5.1 which was then exported to STATA version 12.0 in order to conduct statistical analyses. Descriptive analysis for summary statistics was conducted for the independent variables. The outcome variable was current use of LARC methods which was a binary categorical variable (yes, no). The study computed a prevalence 31.7% for the outcome variable, which is considered to be high therefore Prevalence Risk Ratios (PRR) were used as the appropriate measure of association [24,25]. The PRR was computed for associations between current use of LARC and independent variables using Generalized Linear Model analysis with robust standard errors. Unadjusted PRR were computed with their corresponding 95% confidence intervals (95% CI). The independent variables with a p ≤ 0.10 [26] and biologically plausible factors were included in the multivariable model for multivariable analysis in order to identify their independent predictors of use of LARC. Independent variables identified as statistically significant in the multivariable model were reported as being independently associated with current use of LARC.

Ethics

Ethical approval to conduct this study was obtained from the Makerere University School of Public Health (MakSPH) Higher Degree Research and Ethics Committee on the 22nd February 2012. Informed consent was obtained from all respondents above 18 years in both verbal and written forms. For study participants who were between 15 to 18 years of age, consent and assent was obtained from their parents/guardians and the respondents respectively. Privacy and confidentiality of respondent information was upheld by the research team. Respondent anonymity was observed through use of questionnaire identification numbers. Permission to carry out this study in Lubaga division was obtained from Lubaga division urban council.

Results

The Table  1 shows the baseline characteristics of women aged 15 to 49 years in the study. A total of 565 participants were interviewed from twenty health facilities in Lubaga division, Kampala district. The mean age of the respondents was 26.3 years (SD: 5.34). All 565 respondents that were sampled were eligible for the interview. Among the respondents, 72.6% were married, 46.5% had attended secondary education and 39.3% were Catholics. More than half (56.6%) had delivered between 1 to 3 children in their lifetime.

Table 1.

Characteristics of reproductive aged (15 – 49 years) female respondents in Lubaga division, Mar-Apr 2012

Variable Frequency, N=565 Percentage (%)
Age*
 
 
  15 – 19
34
6.0
  20 – 24
194
34.3
  25 – 29
211
37.3
  30 – 34
78
13.8
  35 - 49
48
8.5
Religion
 
 
  Catholic
222
39.3
  Islam
146
25.8
  Protestant
152
26.9
  Others
45
8.0
Marital status
 
 
  Single
119
20.0
  Married
410
72.6
  Divorced/Widowed
42
7.4
Level of education
 
 
  Primary/Never attended
119
21.1
  Secondary
263
46.5
  Tertiary
183
32.4
Number of children delivered
 
 
  0
139
24.6
  1 – 3
320
56.6
  4+
106
18.8
Ever had an abortion
 
 
  No
445
78.8
  Yes
120
21.2
Previous use of LARC
 
 
  No
230
40.7
  Yes
325
59.3
Current use of LARC
 
 
  No
386
68.3
  Yes 179 31.7

*Range = 15 – 49, mean age (SD) = 26.34 ( 5.35), median (IQR) = 25 (23 – 29).

The proportion of participants currently using LARC methods was 31.7%. Among 565 study participants, about 21% (120 out of 565) reported having ever had an abortion. About 57% (325 of 565) reported having used at least one LARC method prior to current use of LARC at the time of the interview.

Among all study respondents, knowledge of duration of effectiveness of specific LARC methods was generally higher among those currently using LARC methods (Table  2). Among all the study participants, knowledge of effective duration of effectiveness of IUD, implant and injectable contraceptives was 68.5%, 69.9% and 87.4% respectively.

Table 2.

Knowledge of LARC among women of reproductive age in Lubaga division, 2012 (N = 565)

Variable
Total population, N=565
Current use of LARC, N=179
  n (%) n (%)
Knowledge of LARC
 
 
a) Knowledge of duration of protection from pregnancy
IUD
387 (68.5)
136 (75.98)
Implant
395 (69.9)
139 (77.65)
Injectable
494 (87.4)
161 (89.94)
b) Knowledge of site of administration
IUD
429 (75.9)
148 (82.68)
Implant
453 (80.2)
158 (88.27)
Injectable 519 (91.9) 171 (95.53)

Knowledge of administration site for IUD, implant and injectables was 75.9%, 80.2% and 91.9% respectively. Knowledge levels of administration site of specific LARC methods were high among current use of LARC i.e. 82.7%, 88.3% and 95.5% for IUD, implant and injectables respectively (Table  2).

In Table  3, nearly all participants 95% (534 out of 565) agreed that LARC methods can effectively prevent the occurrence of pregnancy. Out of the 565 participants, 513 (90.8%) agreed that health workers should explain the contraceptive side effects to them. About one third of respondents, 32.9% (186 out of 565) agreed that use of LARC can cause permanent infertility.

Table 3.

Attitudes towards use of LARC among respondents in Lubaga division

Items on attitude Agree
Disagree
n (%) n (%)
LARC effectively prevents occurrence of pregnancy
534 (94.5)
31 (5.5)
LARC methods can cause permanent infertility
186 (32.9)
379 (67.1)
LARC should be used by married women
108 (19.1)
513 (80.9)
Partner should decide your contraceptive method to use
272 (48.1)
293 (51.9)
Health workers should explain contraceptive side effects 513 (90.8) 52 (9.2)

Approximately half (48.1%), 272 of 565 respondents agreed that the contraceptive to use is their partners’ decision.

Table  4 shows bivariate analysis of factors associated with current use of LARC methods. Current use of LARC was about one and a half (1.47) times higher among respondents who had children than those who had none (PRR 1.47; 95% CI 1.03, 2.11; p = 0.036). Also, current use of LARC about three times significantly higher among respondents who previously used LARC than those who didn’t previously use LARC (PRR 3.05; 95% CI 2.33, 4.00; p = 0.000). Current use of LARC was significantly increased; approximately 1.46 times higher among respondents with knowledge of duration of protection from pregnancy by IUD and implants (PRR 1.46; 95% CI 1.10, 2.02; p = 0.006) and (PRR 1.45; 95% CI 1.11, 2.02; p = 0.009) respectively than those without knowledge.

Table 4.

Bivariate analysis of independent variables associated with current use of LARC

OUTCOME: Current use of LARC
Independent variable Total Current use of LARC, n (%) Unadjusted PRR (95% CI) p-value
Age (years)
 
 
 
 
 
 < 24
228
65 (36.31)
1
 
 
 ≥ 24
337
114 (63.69)
1.19
(0.92-1.53)
0.187
No. of children delivered
 
 
 
 
 
 None
113
26 (14.53)
1
 
 
 Has children
426
153 (85.47)
1.47
(1.03-2.11)
0.036*
Religion
 
 
 
 
 
 Non catholic
343
107 (59.78)
1
 
 
 Catholic
222
72 (40.2)
1.03
(0.81-1.33)
0.757
Marital status
 
 
 
 
 
 Never married
113
27 (15.08)
1
 
 
 Ever married
452
152 (84.92)
1.41
(0.99-2.01)
0.058
Previous use of LARC
 
 
 
 
 
 No
325
55 (30.73)
1
 
 
 Yes
230
124 (69.27)
3.05
(2.33-4.00)
0.000***
Occupation
 
 
 
 
 
 Unemployed
301
105 (58.66)
1
 
 
 Employed
264
74 (41.34)
0.80
(0.63-1.03)
0.083
Level of education
 
 
 
 
 
 Never attended
115
40 (22.35)
1
 
 
 Attended
446
139 (77.65)
0.90
(0.67-1.19)
0.452
Abortion
 
 
 
 
 
 No
441
137 (76.54)
1
 
 
 Yes
120
42 (23.46)
0.66
(0.34-1.28)
0.217
Knowledge of duration of protection from pregnancy
IUD
 
 
 
 
 
 No
178
43 (24.02)
1
 
 
 Yes
387
136 (75.98)
1.46
(1.10-2.02)
0.006**
Implant
 
 
 
 
 
 No
170
40 (22.35)
1
 
 
 Yes
395
139 (77.65)
1.45
(1.11-2.02)
0.009**
Injectable
 
 
 
 
 
 No
71
18 (10.06)
1
 
 
 Yes
494
161 (89.94)
1.29
(0.85-1.96)
0.240
Knowledge of site of administration
IUD
 
 
 
 
 
 No
136
31 (17.32)
1
 
 
 Yes
429
148 (82.68)
1.51
(1.08-2.12)
0.016*
Implant
 
 
 
 
 
 No
112
21 (11.73)
1
 
 
 Yes
453
158 (88.27)
1.86
(1.24-2.79)
0.003**
Injectable
 
 
 
 
 
 No
46
8 (4.47)
1
 
 
 Yes
519
171 (95.53)
1.89
(0.99-3.61)
0.051
Attitudes towards use of LARC
 
 
 
 
 
LARC should be used by married women
 Disagree
457
156 (87.15)
1
 
 
 Agree
108
23 (12.85)
0.62
(0.43-0.92)
0.016*
Partner should decide your contraceptive use
 Disagree
293
70 (39.11)
1
 
 
 Agree
272
109 (60.89)
1.68
(1.31-2.16)
0.000***
LARC prevents pregnancy occurrence
 Disagree
31
9 (5.03)
1
 
 
 Agree
534
170 (94.97)
1.09
(0.62-1.93)
0.749
Health workers should explain the contraceptive side effects
 Disagree
52
11 (6.15)
1
 
 
 Agree
513
168 (93.85)
1.79
(1.01-3.17)
0.047*
LARC can cause permanent infertility
 Disagree
379
112 (62.57)
1
 
 
 Agree 186 67 (37.43) 1.22 (0.95-1.56) 0.116

Statistically significant at *p < 0.05, **p < 0.01 ***p < 0.001.

On the other hand, current use of LARC methods was significantly reduced if the respondents agreed that LARC should be used by married women (PRR 0.62; 95% CI 0.43, 0.92; p = 0.016).

After adjusting for confounding at multivariable analysis (Table  5), factors that remained significantly associated with current use of LARC were: previous use of LARC (adj.PRR 2.76; 95% CI 2.10,3.62; p = 0.000), knowledge of site of administration of implants (adj.PRR 1.83; 95% CI 1.17,2.87; p = 0.008) and respondents agreeing that their partners should make decisions for their contraceptive to use (adj.PRR 1.49; 95% CI 1.18,1.88; p = 0.000). On the other hand, factors associated with reduced use of LARC currently was respondents agreeing that LARC should be used by married women (adj.PRR 0.63; 95% CI 0.44,0.90; p = 0.000).

Table 5.

Multivariable analysis of factors associated with current use of LARC

OUTCOME: Current use of LARC
  Total Current use of LARC, n (%) Unadjusted (95% CI) PRR Adjusted (95% CI) PRR
Age (years)
 < 24
228
65 (36.31)
1
1
 ≥ 24
337
114 (63.69)
1.19 (0.92-1.53)
1.01 (0.81-1.27)
No. of children delivered
 None
113
26 (14.53)
1
1
 Has children
426
153 (85.47)
1.47 (1.03-2.11)
1.20 (0.85-1.68)
Marital status
 Never married
113
27 (15.08)
1
1
 Ever married
452
152 (84.92)
1.41 (0.99-2.01)
1.12 (0.80-1.58)
Previous use of LARC
 No
325
55 (30.73)
1
1
 Yes
230
124 (69.27)
3.05 (2.33-4.00)
2.89 (2.19-3.81) ***
Knowledge of duration of protection from pregnancy
IUD
 
 
 
 
 No
178
43 (24.02)
1
1
 Yes
387
136 (75.98)
1.46 (1.10-2.02)
1.14 (0.79-1.63)
Implant
 
 
 
 
 No
170
40 (22.35)
1
1
 Yes
395
139 (77.65)
1.45 (1.11-2.02)
0.88 (0.60-1.28)
Knowledge of site of administration
IUD
 
 
 
 
 No
136
31 (17.32)
1
1
 Yes
429
148 (82.68)
1.51 (1.08-2.12)
0.94 (0.65-1.37)
Implant
 
 
 
 
 No
112
21 (11.73)
1
1
 Yes
453
158 (88.27)
1.86 (1.24-2.79)
1.83 (1.17-2.87)
LARC should be used by married women
 Disagree
457
156 (87.15)
1
1
 Agree
108
23 (12.85)
0.62 (0.43-0.92)
0.63 (0.44-0.90) *
Partner should decide your contraceptive to use
 Disagree
293
70 (39.11)
1
1
 Agree
272
109 (60.89)
1.68 (1.31-2.16)
1.49 (1.18-1.88) ***
Health workers should explain contraceptive side effects
 Disagree
52
11 (6.15)
1
1
 Agree 513 168 (93.85) 1.79 (1.01-3.17) 1.45 (0.84-2.49)

Statistically significant at *p < 0.05, ***p < 0.001.

Discussion

The aim of this study was to assess the level of knowledge and attitudes towards LARC methods as well as factors associated with its use among women of reproductive age attending reproductive health services in Lubaga, division Kampala. Whereas the level of knowledge of specific LARC methods in Lubaga division (Table  2) was slightly higher than that of Kampala district [2], it is still sub-optimal. However across the three LARC methods, women had higher levels of knowledge about injectable contraceptives than implants and IUDs. Knowledge of duration of protection from pregnancy was higher for injectable contraceptives than implant and IUD. Knowledge of site of administration for all LARC methods was also relatively high comparable to the national knowledge levels for the three LARC methods [2] suggesting that the needed FP information is reaching the women in Lubaga. The high level of knowledge of LARC methods in our study may be explained by the highly selective group of females selected from health facilities. Lubaga, a peri-urban setting also has a high number of health units which is likely to increase physical access to FP services including contraceptive counseling. However, there is need for further research into why the high level of knowledge does not translate into actual higher use of LARC in this urban setting [2].

Low use of LARC may be due to misconceptions about causation of permanent infertility (Table  3). A survey in Ghana, revealed that women had high knowledge levels of IUD but cited its side effects as the main reason for non-use [27]. Similarly, studies in Kenya and Nigeria revealed that among injectable and implanon (implant) users respectively, misconceptions [28], side effects [28,29] and husbands’ opposition [28] were main reasons for their discontinuation.

In contrast, a study in Jimma, Ethiopia, revealed that women were least knowledgeable about IUD and more knowledgeable about implants and injectables especially among married couples [30]. The difference in findings could be explained by the fact that the Ethiopian study was conducted among married couples which could have been a highly self-selected group that had jointly agreed to use LARC.

In a study in rural Ethiopia, knowledge of IUD was much lower at 13.1% [31] when compared with knowledge of IUD in this study in Lubaga division. Though knowledge of injectable contraceptives (97.8%) is nearly universal when compared to this study in Lubaga, knowledge of implants (74.4%) was comparable [31]. These study differences in knowledge of IUD and implants could potentially be due to rural–urban differences in socio-demographics and availability of specific LARC methods. Since injectable contraceptives are the predominant LARC method currently used in both studies, this may suggest that injectable contraceptives are the LARC method mostly available. Provision of injectable contraceptives at both community and facility levels when compared to facility provision of implants and IUD in some sub-Saharan countries like Nigeria [32], Madagascar [33], Ethiopia [34] and also Uganda [35,36] could have contributed to high injectable contraceptive knowledge and current use.

Nearly half (48.1%) of the women in this study thought that their male partners should decide on the contraceptive to use (Table  3) suggesting that socio-cultural perceptions play an important part in the contraceptive choices made. A study in Kenya and Ethiopia found that partner approval [37] and husband support [38] influences use of FP services and contraceptives respectively. Our study in Lubaga had similar findings on partner’s decision on spouses’ choice of contraceptive. Partner decision was associated with women’s contraceptive use similar to findings from Ghana, Nigeria and Rwanda where partner approval, partner’s support [39,40] or partner objections [41-43] towards contraceptive choice influenced contraceptive use. In South Africa, women that strongly agreed to male decision making regarding child-bearing did not influence effective contraception [44]. In Uganda [45,46] and Burkina Faso [47], scientific evidence has also shown that positive influence of male partners may affect maternal and child health outcomes. Nearly half of the women in this study thought that their male partners should decide the contraceptive to use therefore socio-cultural perceptions in Lubaga especially related to roles of males and females in decision making in families might explain these attitudes among women.

In Nigeria, [48] and Bangladesh [42], acceptors of long acting contraception were more likely to be married women. A study in Nigeria consistent with our study showed that almost half of the married women had previously used IUD and injectables [49]. Since comparable proportions of use of LARC in all three studies were married women, this may suggest that they may have good attitudes towards using LARC methods.

The findings of our study should be interpreted in light of some limitations; the study was cross-sectional therefore we could not establish temporality between current use of LARC and the independent factors. Since the study relied on the respondents’ self-report, there could have been potential for recall bias about the history related to use of LARC methods. We attempted to control for potential confounders of known factors in the multivariable analysis. Misclassification bias may have been introduced when collapsing attitude items from a 5 to 3 point likert scales, the new categorization assumed that those reporting “unsure” disagreed. However, given the small number of responses in the “unsure” category this is unlikely to have greatly biased the results. Suggestion for future research could include conducting qualitative data collection methods in order to adequately assess behaviors of women associated with contraceptive use.

Conclusion

This study revealed a relatively low level of current use of LARC among women attending clinics in Lubaga, Kampala. Knowledge of site of administration of implants, previous use, and women’s attitude about the important role of male partners in their choice of contraceptives was associated with current use of LARC. Strategies to strengthen client education may be integrated within reproductive health programs in Lubaga division in order to dispel possible myths about LARC. Involving males in the decision making process of contraceptives may also be integrated into strategies to promote family planning services.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RA was the principal investigator, originated the study idea, developed the protocol and manuscript drafting and also applied for the FHRDC grant. RT reviewed the study protocol, contributed significantly to statistical analysis and manuscript drafting. JS mentored the author, supervised the manuscript development and revised the methodology. VZ, TS and CM contributed to statistical analysis of the study. DS was the primary supervisor of the author and contributed to statistical analysis. All authors read and approved the final manuscript.

Contributor Information

Ronald Anguzu, Email: ronaldanguzu@yahoo.com.

Raymond Tweheyo, Email: ratweheyo@yahoo.co.uk.

Juliet N Sekandi, Email: Juliet.sekandi5@gmail.com.

Vivian Zalwango, Email: zalvivian@yahoo.com.

Christine Muhumuza, Email: cmuhumuza@musph.ac.ug.

Suzan Tusiime, Email: tatwooki@yahoo.com.

David Serwadda, Email: dserwada@imul.com.

Acknowledgments

The corresponding author is a recipient of a research grant from the Family Health Research and Development Centre (FHRDC) of Makerere University School of Public Health in order to conduct this study. Appreciation goes to FHRDC (in partnership with Bill and Melinda Gates Institute for Population and Reproductive Health) whose grant facilitated this research. Appreciation also goes to Mr. Roland Kusiima for his contribution to the statistical analysis. A lot of thanks also go to the research assistants, health unit heads and the study participants from selected health centers in Lubaga division for data collection.

References

  1. PRB. World Population Data Sheet. Washington, DC; 2013. pp. 1–20. [Google Scholar]
  2. UBOS. Uganda Demographic and Health Survey 2011. 2011. [cited 2013 10th July]; Available from: http://www.ubos.org/onlinefiles/uploads/ubos/UDHS/UDHS2011.pdf.
  3. Nalwadda G, Mirembe F, Byamugisha J, Faxelid E. Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives. BMC Public Health. 2010;10:530. doi: 10.1186/1471-2458-10-530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Singh S, Prada E, Mirembe F, Kiggundu C. The incidence of induced abortion in Uganda. Int Fam Plan Perspect. 2005;31(4):183–191. doi: 10.1363/3118305. [DOI] [PubMed] [Google Scholar]
  5. Paul VK, Sachdev HS, Mavalankar D, Ramachandran P, Sankar MJ, Bhandari N, Sreenivas V, Sundararaman T, Govil D, Osrin D. Reproductive health, and child health and nutrition in India: meeting the challenge. Lancet. 2011;377(9762):332–349. doi: 10.1016/S0140-6736(10)61492-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Stover J, Ross J. How increased contraceptive Use has reduced maternal mortality. Matern Child Health J. 2010;14(5):687–695. doi: 10.1007/s10995-009-0505-y. [DOI] [PubMed] [Google Scholar]
  7. MoH. The National Policy Guidelines and Service Standards for Reproductive Health Services. 2001. [cited 2013 10th July]; Available from: http://www.youth-policy.com/Policies/Uganda%20National%20Policy%20Guidelines%20and%20Service%20Standards%20for%20Reproductive%20Health%20Services.pdf.
  8. UN. Contraceptive Commodities for Women’s Health, in Key Data and Findings. New York: United Nations Commission on Life-Saving Commodities for Women and Children; 2012. pp. 1–29. [Google Scholar]
  9. UNFPA. United Nations High Level Meeting on Reproductive Health Commodity Security. New York: United Nations; 2011. pp. 1–40. [Google Scholar]
  10. Mitchel MT, Thistle P. Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe. Contraception. 2004;70(6):483–486. doi: 10.1016/j.contraception.2004.05.004. [DOI] [PubMed] [Google Scholar]
  11. Masters T, Everett S. Intrauterine and barrier contraception (a practical review of recent developments) Curr Obstet Gynaecol. 2005;15(1):31–37. doi: 10.1016/j.curobgyn.2004.09.004. [DOI] [Google Scholar]
  12. Blumenthal PD, Voedisch A, Gemzell-Danielsson K. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Hum Reprod Update. 2011;17(1):121–137. doi: 10.1093/humupd/dmq026. [DOI] [PubMed] [Google Scholar]
  13. Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705–719. doi: 10.1097/AOG.0b013e31820ce2f0. [DOI] [PubMed] [Google Scholar]
  14. Roberts A, Noyes J. Contraception and women over 40 years of age: mixed-method systematic review. J Adv Nurs. 2009;65(6):1155–1170. doi: 10.1111/j.1365-2648.2009.04976.x. [DOI] [PubMed] [Google Scholar]
  15. Bongaarts J, Johansson E. Future trends in contraceptive prevalence and method Mix in the developing world. Stud Fam Plann. 2002;33(1):24–36. doi: 10.1111/j.1728-4465.2002.00024.x. [DOI] [PubMed] [Google Scholar]
  16. Creanga AA, Gillespie D, Karklins S, Tsui AO. Low use of contraception among poor women in Africa: an equity issue. Bull World Health Organ. 2011;89:258–266. doi: 10.2471/BLT.10.083329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MoFPED. Millennium Development Goals Report for Uganda 2010. Special theme: Accelerating progress towards improving maternal health; 2010. [cited 2013 10th July]; Available from: http://www.undp.org/content/dam/undp/library/MDG/english/MDG%20Country%20Reports/Uganda/Uganda_MDGs_Report_2010.pdf. [Google Scholar]
  18. MoFPED. Sub National Projections Report, Central Region 2008–2012. Kampala: Uganda Bureau of Statistics; 2008. [Google Scholar]
  19. KCC. 3 Year Rolling Development Plan. Kampala: Kampala City Council; 2010. [Google Scholar]
  20. Kish L. Sampling organizations and groups of unequal sizes. American sociological review; 1965. pp. 564–572. [PubMed] [Google Scholar]
  21. UBOS. Uganda Demographic and Health Survey 2006. 2006. [cited 2013 10th July]; Available from: http://www.ubos.org/onlinefiles/uploads/ubos/pdf%20documents/Uganda%20DHS%202006%20Final%20%20Report.pdf.
  22. Tamire W, Enqueselassie F. Knowledge, attitude, and practice on emergency contraceptives among female university students in Addis Ababa, Ethiopia. Ethiop J Health Dev. 2007;21(2):111–116. [Google Scholar]
  23. Alemayehu M, Belachew T, Tilahun T. Factors associated with utilization of long acting and permanent contraceptive methods among married women of reproductive age in Mekelle town, Tigray region north Ethiopia. BMC Pregnancy Childbirth. 2012;12(1):6. doi: 10.1186/1471-2393-12-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200. doi: 10.1093/aje/kwi188. [DOI] [PubMed] [Google Scholar]
  25. Schmidt CO, Kohlmann T. When to use the odds ratio or the relative risk? Int J Public Health. 2008;53(3):165–167. doi: 10.1007/s00038-008-7068-3. [DOI] [PubMed] [Google Scholar]
  26. Kavanaugh ML, Carlin EE, Jones RK. Patients’ attitudes and experiences related to receiving contraception during abortion care. Contraception. 2011;84(6):585–593. doi: 10.1016/j.contraception.2011.03.009. [DOI] [PubMed] [Google Scholar]
  27. Gyapong J, Addico G, Osei I, Abbey M, Kobinah D. An assessment of trends in the use of the IUD in Ghana. 2003. pp. 1–35.
  28. Burke H, Ambasa-Shisanya C. Qualitative study of reasons for discontinuation of injectable contraceptives among users and salient reference groups in Kenya. Afr J Reprod Health. 2011;15(2):67–78. [PubMed] [Google Scholar]
  29. Ezegwui H, Ikeako L, Ishiekwene C, Oguanua T. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu. Nigeria. Niger J Med. 2011;20(4):448. [PubMed] [Google Scholar]
  30. Tilahun T, Coene G, Luchters S, Kassahun W, Leye E, Temmerman M, Degomme O. Family planning knowledge, attitude and practice among married couples in Jimma Zone, Ethiopia. PLoS One. 2013;8(4):e61335. doi: 10.1371/journal.pone.0061335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mekonnen W, Worku A. Determinants of low family planning use and high unmet need in Butajira District, South Central Ethiopia. Reprod Heal. 2011;8:37. doi: 10.1186/1742-4755-8-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Abdul-hadi RA, Abass MM, Aiyenigba BO, Oseni LO, Odafe S, Chabikuli ON, Ibrahim MD, Hamelmann C, Ladipo OA. The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria: original research article. Afr J Reprod Health. 2013;17(2):80. [PubMed] [Google Scholar]
  33. Hoke TH, Wheeler SB, Lynd K, Green MS, Razafindravony BH, Rasamihajamanana E, Blumenthal PD. Community-based provision of injectable contraceptives in Madagascar: ‘task shifting’ to expand access to injectable contraceptives. Health Policy Plan. 2012;27(1):52–59. doi: 10.1093/heapol/czr003. [DOI] [PubMed] [Google Scholar]
  34. Prata N, Gessessew A, Cartwright A, Fraser A. Provision of injectable contraceptives in Ethiopia through community-based reproductive health agents. Bull World Health Organ. 2011;89(8):556–564. doi: 10.2471/BLT.11.086710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stanback J, Mbonye AK, Bekiita M. Contraceptive injections by community health workers in Uganda: a nonrandomized community trial. Bull World Health Organ. 2007;85(10):768–773. doi: 10.2471/BLT.07.040162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stanback J, Miller R. Radical Common Sense: Community Provision of Injectable Contraception in Africa, in Critical Issues in Reproductive Health. Berlin: Springer; 2014. pp. 265–284. [Google Scholar]
  37. Okech TC, Wawire DNW, Mburu DTK. Contraceptive use among women of reproductive age in Kenya’s City Slums. Int J Bus Soc Sci. 2011;2 No. 1; January 2011. [Google Scholar]
  38. Adugnaw B, Sibhatu B, Alemayehu A, Sudhakar M, Alemayehu B, Kebede D. Men’s knowledge and spousal communication about modern family planning methods in Ethiopia. Afr J Reprod Health. 2011;15:24–32. [PubMed] [Google Scholar]
  39. Chigbu B, Onwere S, Aluka C, Kamanu C, Okoro O, Feyi-Wboso P. Contraceptive choices of women in rural Southeastern Nigeria. Niger J Clin Pract. 2010;13(2):195–199. [PubMed] [Google Scholar]
  40. Brunie A, Tolley EE, Ngabo F, Wesson J, Chen M. Getting to 70%: barriers to modern contraceptive use for women in Rwanda. Int J Gynecol Obstet. 2013;123:e11–e15. doi: 10.1016/j.ijgo.2013.07.005. [DOI] [PubMed] [Google Scholar]
  41. Omideyi AK, Akinyemi AI, Aina OI, Adeyemi AB, Fadeyibi OA, Bamiwuye SO, Akinbami CA, Anazodo A. Contraceptive practice, unwanted pregnancies and induced abortion in Southwest Nigeria. Glob Public Health. 2011;6(sup1):S52–S72. doi: 10.1080/17441692.2011.594073. [DOI] [PubMed] [Google Scholar]
  42. Nayer I, Akter S, Hossain S, Luci R. Acceptance of long-term contraceptive methods and its related factors among the eligible couples in a selected union. Bangladesh Med Res Counc Bull. 2004;30(1):31. [PubMed] [Google Scholar]
  43. Chigbu CO, Onyebuchi AK, Onwudiwe EN, Iwuji SE. Denial of women’s rights to contraception in southeastern Nigeria. Int J Gynaecol Obstet. 2013;121(2):154–156. doi: 10.1016/j.ijgo.2012.12.010. [DOI] [PubMed] [Google Scholar]
  44. Peer N, Morojele N, London L. Factors associated with contraceptive use in a rural area in Western Cape Province. S Afr Med J. 2013;103(6):406–412. doi: 10.7196/samj.6201. [DOI] [PubMed] [Google Scholar]
  45. Tweheyo R, Konde-Lule J, Tumwesigye NM, Sekandi JN. Male partner attendance of skilled antenatal care in peri-urban Gulu District, Northern Uganda. BMC Pregnancy Childbirth. 2010;10:53. doi: 10.1186/1471-2393-10-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kakaire O, Kaye DK, Osinde MO. Male involvement in birth preparedness and complication readiness for emergency obstetric referrals in rural Uganda. Reprod Health. 2011;8:12. doi: 10.1186/1742-4755-8-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hounton S, Byass P, Brahima B. Towards reduction of maternal and perinatal mortality in rural Burkina Faso: communities are not empty vessels. Global health action. 2009;2:1–9. doi: 10.3402/gha.v2i0.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Adeyemi A, Adekanle D, Komolafe J. Pattern of contraceptives choice among the married women attending the family planning clinic of a tertiary health institution. Niger J Med. 2008;17(1):67–70. doi: 10.4314/njm.v17i1.37359. [DOI] [PubMed] [Google Scholar]
  49. Aliyu A, Shehu A, Sambo M, Sabitu K. Contraceptive knowledge, attitudes and practice among married women in Samaru Community, Zaria, Nigeria. East Afr J Public Health. 2011;7(4):342–344. doi: 10.4314/eajph.v7i4.64757. [DOI] [PubMed] [Google Scholar]

Articles from BMC Research Notes are provided here courtesy of BMC

RESOURCES